APQ Health (formerly Cedars-Sinai Medical Center: AIM)
About APQ Health (formerly Cedars-Sinai Medical Center: AIM)
APQ Health is a health technology company that specializes in AI-powered, automated quantitative analysis of 3D medical images, with a primary focus on cardiovascular diagnostics. The company is the exclusive worldwide licensee of Autoplaque®, an FDA-cleared AI software platform initially developed at Cedars-Sinai by APQ Health’s founders. Autoplaque® provides deep learning-enabled quantification of coronary atherosclerosis, including plaque burden, characterization of plaque features (such as low-attenuation, vulnerable plaque), and stenosis assessment from CCTA scans.
For physicians, APQ Health’s technology offers a powerful tool for enhanced cardiac risk stratification and treatment guidance. The Autoplaque® software has been validated across 35 academic sites and is backed by over 100 peer-reviewed publications, including the landmark SCOT-HEART multicenter trial. It demonstrates a 95% agreement with invasive IVUS and a 0.95 correlation with expert readers. By providing quantitative information on total plaque volume, identification of vulnerable plaque burden, and prediction of patient-specific myocardial infarction risk, APQ Health aims to translate clinically validated imaging innovations into practical tools that support clinical evaluation and improve patient outcomes.
Focus Areas
Business Intelligence
| Technology | AI-powered, deep learning-enabled software for automated quantitative analysis of 3D medical images (Autoplaque®) |
What Physicians Need to Know
For physicians, APQ Health's Autoplaque offers a robust, FDA-cleared tool for automated, quantitative coronary plaque analysis from CCTA. This can significantly enhance risk stratification for cardiovascular events, particularly myocardial infarction, by providing detailed insights into plaque volume and characteristics beyond traditional stenosis measurements. The evidence-driven nature, backed by extensive peer-reviewed research and clinical validation, provides confidence in its utility for guiding treatment decisions and tailoring preventive therapies. The AI-powered analysis can also save considerable time compared to manual plaque assessment, allowing physicians to focus more on patient counseling and treatment planning. Furthermore, the ability to glean crucial heart health insights from routine CT scans, even without contrast, can make detailed heart evaluations more accessible and less invasive for patients.
While specific details about APQ Health's technology stack for integration were not explicitly detailed, healthcare AI solutions typically rely on robust infrastructure layers (cloud platforms, data centers), data layers (databases, data lakes, and formats like HL7 and FHIR), and integration layers (middleware, APIs, and message brokers) to connect with existing hospital systems like EHRs and imaging archives. APQ Health's partnership with Catalyst MedTech to expand access to their CCTA viewer software and Autoplaque analysis services suggests a focus on streamlined workflows that combine on-site image review with access to advanced, FDA-cleared plaque quantification and reporting, potentially through flexible deployment options (on-premises or remote services). This indicates an emphasis on interoperability and ease of integration into clinical workflows to support physician interpretation and documentation.
What the Web Says
APQ Health, formerly known as Cedars-Sinai Medical Center: AIM, is a health-tech startup that develops AI-powered software for analyzing medical images, specifically Autoplaque for coronary plaque analysis. Cedars-Sinai also utilizes AI in various other capacities, including a virtual platform called Cedars-Sinai Connect for 24/7 patient support and Regard's AI diagnostic support. Reviews for Cedars-Sinai as an employer are mixed, with many highlighting excellent benefits and opportunities for growth, but also pointing out issues with management, workload, and workplace culture in some departments.
Overall: MixedStrengths
- Excellent benefits and competitive pay.
- Opportunities for learning and professional growth within the organization.
- High quality of patient care.
- Supportive coworkers and friendly environment in many departments.
- AI tools like Autoplaque and CS Connect show promising results in improving diagnostics and patient access.
- Diversity in employee demographics.
Limitations
- Weak or poor management in some areas, with concerns about favoritism and lack of recognition.
- High-stress and rigid work culture in some departments, leading to staff being overworked.
- Low pay for the amount of work and high cost of living in Los Angeles.
- Dysfunctional and toxic workplace culture in certain units, including instances of bullying.
- Limited professional growth opportunities in some roles.
- Long wait times for appointments and challenges with referrals for specialists.
Based on reviews from: Comparably, Reddit, Indeed.com, Zippia, AHA, Business Insider, APQ Health, Trustpilot, Medicare, Capterra, G2
Last updated: 2026-10-18
Videos
News, demos, and interviews about APQ Health (formerly Cedars-Sinai Medical Center: AIM).
Videos load interactively. If none appear, search YouTube for APQ Health (formerly Cedars-Sinai Medical Center: AIM) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]